UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2011
Commission File Number: 001-34541
CHINA CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
48th Floor, Bank of China Tower
1 Garden Road
Central
|
Hong Kong S.A.R.
|
||
|
(Address of Principal Executive Offices)
|
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.
Other Events
On December 19, 2011, China Cord Blood Corporation (the “Company”) issued a press release announcing the results of its 2011 Annual General Meeting, which was held on December 19, 2011, in Hong Kong. At the Annual General Meeting, shareholders: (1) elected Ms. Ting Zheng and Dr. Yungang (Ken) Lu to serve on the Board of Directors until the 2014 annual general meeting of the Company or until their respective successors are duly appointed and qualified; and (2) ratified the appointment of KPMG as auditor of the Company for the financial year ending March 31, 2012, and authorized the directors to set the remuneration of the auditors. A copy of the press release is attached hereto as exhibit 99.1.
Exhibits
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release, dated December 19, 2011, regarding results of annual general meeting
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CHINA CORD BLOOD CORPORATION
|
||
|
By:
|
/s/ Albert Chen
|
|
|
Name:
|
Albert Chen
|
|
|
Title:
|
Chief Financial Officer
|
|
Dated: December 21, 2011
Exhibit 99.1
China Cord Blood Corporation Announces
Results of 2011 Annual General Meeting
HONG KONG , Dec. 19, 2011 /PRNewswire-Asia-FirstCall/ — China Cord Blood Corporation (NYSE: CO - News) ("CCBC" or the "Company"), the first and largest umbilical cord blood banking operator in China , today announced the results of its 2011 Annual General Meeting, which was held on December 19, 2011, in Hong Kong .
At the Annual General Meeting, shareholders
|
|
·
|
Elected Ms. Ting Zheng and Dr. Yungang ( Ken) Lu to serve on the Board of Directors until the 2014 Annual General Meeting of the Company or until their respective successors are duly appointed and qualified; and
|
|
|
·
|
Ratified the appointment of KPMG as the independent auditor of the Company for the financial year ending March 31, 2012, and authorized the directors to fix the remuneration of the auditors.
|
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Ms. Joeling Law
Tel: (+852) 3605-8180
Email: [email protected]
ICR, Inc.
In New York : Ashley M. Ammon : 1-646-277-1227
In Beijing : Wen Lei Zheng : +86-10-6583-7510